Experience of remote monitoring of treatment quality in patients with arterial hypertension during the current pandemic period
- Authors: Bekhbudova D.A.1, Akhmedova T.A.1, Abieva E.M.1, Israfilbekova F.R.1, Dadashova G.M.1
-
Affiliations:
- Scientific Research Institute of Cardiology named after Academician J.M. Abdullaev
- Issue: Vol 40, No 1 (2023)
- Pages: 53-60
- Section: Original studies
- URL: https://journals.rcsi.science/PMJ/article/view/144131
- DOI: https://doi.org/10.17816/pmj40153-60
- ID: 144131
Cite item
Full Text
Abstract
Objective. To conduct a retrospective assessment of the dynamics of blood pressure (BP), the quality of antihypertensive therapy and the frequency of contacts with doctors in conditions of pandemic among patients with hypertension identified during a preventive examination of the population in an organized population of Baku.
Materials and methods. Two groups of patients were studied: group 1 – patients with hypertension who were aware of their disease before the start of the preventive examination; group 2 – patients who were diagnosed hypertension for the first time during the preventive examination. The results of the survey of these patients according to the questionnaire by means of telephone contacts, which includes questions regarding the control of blood pressure (BP), taking antihypertensive drugs, frequency of visiting doctors for 2 years after the initial preventive examination were studied.
Results. The results, obtained in group 1, indicate that taking antihypertensive drugs without periodic medical control over the effectiveness of therapy in most cases does not allow achieving the target values of blood pressure. The results, obtained in group 2, demonstrate poor adherence of patients to medical recommendations and justify the need to create a system of active detection and monitoring of persons with hypertension, who do not know about their disease.
Conclusions. It is necessary to create such a system of remote monitoring of newly identified and registered patients with hypertension, which based on modern technological advances, would allow patients to contact doctors (including remote ones) with a calculated frequency, and thus would ensure regular monitoring of the quality of treatment and adherence to recommendations regarding the treatment and prevention of cardiovascular diseases.
Full Text
##article.viewOnOriginalSite##About the authors
D. A. Bekhbudova
Scientific Research Institute of Cardiology named after Academician J.M. Abdullaev
Author for correspondence.
Email: Statya2021@mail.ru
Candidate of Medical Sciences, Head of the Department of Preventive Cardiology
Azerbaijan, BakuT. A. Akhmedova
Scientific Research Institute of Cardiology named after Academician J.M. Abdullaev
Email: Statya2021@mail.ru
researcher of the Department of Preventive Cardiology
Azerbaijan, BakuE. M. Abieva
Scientific Research Institute of Cardiology named after Academician J.M. Abdullaev
Email: Statya2021@mail.ru
Candidate of Medical Sciences, senior researcher of the Department of Preventive Cardiology
Azerbaijan, BakuF. R. Israfilbekova
Scientific Research Institute of Cardiology named after Academician J.M. Abdullaev
Email: Statya2021@mail.ru
Candidate of Medical Sciences, senior researcher of the Department of Preventive Cardiology
Azerbaijan, BakuG. M. Dadashova
Scientific Research Institute of Cardiology named after Academician J.M. Abdullaev
Email: Statya2021@mail.ru
MD, PhD, Director
Azerbaijan, BakuReferences
- Korostovtseva L.S. Arterial'naya gipertenziya. Arterial hypertension 2020; 2: 124–132. doi: 10.18705/1607-419X-2020-26-2-124-132 PDF(RUS) (in Russian).
- Mamedov M. Kardiovaskulyarnaya terapiya i profilaktika. Cardiovascular therapy and prevention 2021; 20(4): 2910. DOI: 10.15829/ 1728-8800-2021-20-4-2910 (in Russian).
- Muromtseva G.A., Kontsevaya A.V., Konstantinov V.V. i dr. Kardiovaskulyarnaya terapiya i profilaktika. Cardiovascular therapy and prevention 2014; 13(6): 4–11 (in Russian).
- Global Burden of Disease Risk Factor Collaborators. Global, regional and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risk for 95 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1923–94.
- Boitsov S.A., Balanova Yu.A., Shal'nova S.A. i dr. (51 avt) Kardiovaskulyarnaya terapiya i profilaktika. Cardiovascular therapy and prevention 2014; 13(4): 4–14. doi: 10.15829/1728-8800-2014-4-4-14 (in Russian).
- Shal'nova S.A., Balanova Yu.A., Konstantinov V.V., Kapustina A.V., Deev A.D. Ros. kardiol. zhurn. Ros. cardiol. journal 2006; 4(60): 45–50 (in Russian).
- Mills K.T., Bunday J.D., Kelly T.N., Reed J.E., Kearney P.M., Reynolds K., Chen J., He J. Global disparities of hypertension prevalence and control: a systematic analysis of population – based studies from 90 countries. Circulation 2016; 134 (6): 441–50. doi: 10.1161/CIRCULATIONAHA.115.018912.